Weight loss drugs have become an increasingly popular, but controversial, way of quickly shedding extra pounds over the past ...

A North Texas woman with a cautionary tale warns others to do their research before starting popular weight loss drugs.

Limited effectiveness, weight regain, and high prevalence of adverse events are the three key limitations of semaglutide ...

Obesity increases the risk of numerous secondary diseases such as type 2 diabetes, high blood pressure and mental illness. Prof. Dr. Kerstin Stemmer, Professor of Molecular Cell Biology at the ...

The weight-loss drug Wegovy slashes the risk of heart disease even before people shed many pounds, data suggests.The drug, which contains the active ingredient semaglutide, works by reducing food ...

As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...

A digital obesity clinic, Embla, is associated with 16.7% weight loss over 64 weeks, matching previous semaglutide trial ...